ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation

[1]  P. Farup,et al.  Anti-Saccharomyces cerevisiae antibodies ( ASCA ) are associated with body fat mass and systemic inflammation , but not with dietary yeast consumption : a cross-sectional study , 2017 .

[2]  M. Abu Tailakh,et al.  Inflammatory bowel disease among Bedouin Arabs in southern Israel: urbanization and increasing prevalence rates , 2015, European journal of gastroenterology & hepatology.

[3]  M. Sparrow,et al.  Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes. , 2015, Autoimmunity reviews.

[4]  O. Saadah,et al.  Serological markers of inflammatory bowel disease in children from the Western region of Saudi Arabia. , 2013, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

[5]  A. Esmaeilzadeh,et al.  Diagnostic Value of ASCA and Atypical p-ANCA in Differential Diagnosis of Inflammatory Bowel Disease , 2013, Middle East journal of digestive diseases.

[6]  Zhaoxia Zhang,et al.  Anti-Saccharomyces cerevisiae Antibodies Associate with Phenotypes and Higher Risk for Surgery in Crohn’s Disease: A Meta-Analysis , 2012, Digestive Diseases and Sciences.

[7]  A. Amouri,et al.  Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel disease , 2011, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[8]  I. Lochman,et al.  ANCA in the diagnosis of neutrophil-mediated inflammation. , 2011, Autoimmunity reviews.

[9]  D. Shahar,et al.  Importance of ethnic foods as predictors of and contributors to nutrient intake levels in a minority population , 2010, European Journal of Clinical Nutrition.

[10]  G. Veres,et al.  Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease , 2009, Clinical and Vaccine Immunology.

[11]  M. Papp,et al.  Utility of serological markers in inflammatory bowel diseases: gadget or magic? , 2007, World journal of gastroenterology.

[12]  C. Kallenberg,et al.  Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides , 2006, Nature Clinical Practice Rheumatology.

[13]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[14]  R. Balicer,et al.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.

[15]  B. Sands,et al.  A male with a pelvic mass , 2004, Gut.

[16]  A. Wiik,et al.  Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. , 2003, American journal of clinical pathology.

[17]  A. Wiik.  Rational use of ANCA in the diagnosis of vasculitis. , 2002, Rheumatology.

[18]  M. Daperno,et al.  Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker? , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  A. Zinsmeister,et al.  Evaluation of Serologic Disease Markers in a Population-Based Cohort of Patients with Ulcerative Colitis and Crohn's Disease , 2001, Inflammatory bowel diseases.

[20]  P. Rutgeerts,et al.  Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[21]  S. Targan,et al.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics , 2000, Gut.

[22]  S. Targan,et al.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.

[23]  M. Kerr,et al.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.

[24]  A. Mokrowiecka,et al.  Clinical utility of serological markers in inflammatory bowel disease. , 2009, Hepato-gastroenterology.